Download Free Va Health Care Weaknesses In Policies And Oversight Governing Medical Supplies And Equipment Pose Risks To Veterans Safety Book in PDF and EPUB Free Download. You can read online Va Health Care Weaknesses In Policies And Oversight Governing Medical Supplies And Equipment Pose Risks To Veterans Safety and write the review.

The Department of Veterans Affairs (VA) clinicians use expendable medical supplies ¿ disposable items that are generally used one time ¿ and reusable medical equipment (RME), which is designed to be reused for multiple patients. VA has policies that VA medical centers (VAMC) must follow when purchasing such supplies and equipment, tracking these items at VAMCs, and reprocessing ¿ that is, cleaning, disinfecting, and sterilizing ¿ RME. This report evaluates: (1) purchasing, tracking, and reprocessing requirements in VA policies; and (2) VA¿s oversight of VAMCs¿ compliance with these requirements. Includes recommendations. Charts amd tables. This is a print on demand edition of an important, hard-to-find publication.
VA Health Care: Weaknesses in Policies and Oversight Governing Medical Equipment Pose Risks to Veterans' Safety
VA Health Care: Weaknesses in Policies and Oversight Governing Medical Supplies and Equipment Pose Risks to Veterans' Safety
Department of Veterans Affairs (VA) clinicians use expendable medical supplies, disposable items that are generally used one time, and reusable medical equipment (RME), which is designed to be reused for multiple patients. VA has policies that VA medical centers (VAMC) must follow when purchasing such supplies and equipment, tracking these items at VAMCs, and reprocessing, that is, cleaning, disinfecting, and sterilizing, RME. GAO was asked to evaluate (1) purchasing, tracking, and reprocessing requirements in VA policies and (2) VA's oversight of VAMCs' compliance with these requirements. GAO reviewed VA policies and selected two purchasing requirements, two tracking requirements, and two reprocessing requirements. At the six VAMCs GAO visited, GAO interviewed officials and reviewed documents to examine the adequacy of the selected requirements to help ensure veterans' safety. GAO also interviewed officials from VA headquarters and from six Veterans Integrated Service Networks (VISN), which oversee VAMCs, and obtained and reviewed documents regarding VA's oversight. GAO is making several recommendations for VA to address the inadequacies identified in selected tracking and reprocessing requirements and the weaknesses in its oversight over selected purchasing and reprocessing requirements. VA concurred with these recommendations.

VA and Human Tissue

United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Oversight and Investigations

Published: 2015

Total Pages: 64


Get eBook

The theme of this volume on systems engineering research is disciplinary convergence: bringing together concepts, thinking, approaches, and technologies from diverse disciplines to solve complex problems. Papers presented at the Conference on Systems Engineering Research (CSER), March 23-25, 2017 at Redondo Beach, CA, are included in this volume. This collection provides researchers in academia, industry, and government forward-looking research from across the globe, written by renowned academic, industry and government researchers.
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.